Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [916]

Banking on biomarkers – improving the diagnosis of early stage NSCLC

Dr Harvey Pass - New York University Langone Medical Center, New York, USA

Banking on biomarkers – improving the diagnosis of early stage NSCLC ( Dr Harvey Pass - New York University Langone Medical Center, New York, USA )

Moving precision medicine for lung cancer into the adjuvant setting

Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA

Moving precision medicine for lung cancer into the adjuvant setting ( Dr Don Gibbons - The University of Texas MD Anderson Cancer Center, Houston, USA )

SPRING – rolling tri-therapy combinations of targeted drugs in second line of...

Prof Razelle Kurzrock - University of California, San Diego, USA

SPRING – rolling tri-therapy combinations of targeted drugs in second line of metastatic NSCLC ( Prof Razelle Kurzrock - University of California, San Diego, USA )

SPECTAlung: improving clinical trial access for patients with thoracic tumours

Dr Jessica Menis and Dr Benjamin Besse

SPECTAlung: improving clinical trial access for patients with thoracic tumours ( Dr Jessica Menis and Dr Benjamin Besse )

PDL1 expression in thymic tumours

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA

PDL1 expression in thymic tumours ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer

Dr Emiliano Calvo - START Madrid, Madrid, Spain

PM1183 plus doxorubicin shows interesting activity in small cell lung cancer ( Dr Emiliano Calvo - START Madrid, Madrid, Spain )

Round-up of the latest research on lung cancer

Dr James Spicer - Guy's Hospital, London, UK

Round-up of the latest research on lung cancer ( Dr James Spicer - Guy's Hospital, London, UK )

Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma

Prof Yilong Wu - President of the Chinese Society of Clinical Oncology

Preliminary analysis on the RNA sequencing data of lung squamous cell carcinoma ( Prof Yilong Wu - President of the Chinese Society of Clinical Oncology )

Developments in clinical trials and health information technology that will...

Dr Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, USA

Developments in clinical trials and health information technology that will improve targeted therapies for patients ( Dr Clifford Hudis, Memorial Sloan Kettering Cancer Center, New York, USA )

Next generation inhibitors help overcome problems of resistance in ALK positive...

Dr Ross Camidge - University of Colorado, Denver, USA

Next generation inhibitors help overcome problems of resistance in ALK positive lung cancer ( Dr Ross Camidge - University of Colorado, Denver, USA )

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse...

Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA

Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction ( Dr Lynn Schuchter - University of Pennsylvania, Philadelphia, USA )

Genomic marker predicts anti-PD-1 response in several cancers

Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA

Genomic marker predicts anti-PD-1 response in several cancers ( Dr Dung Le - Johns Hopkins Kimmel Cancer Center, Baltimore, USA )

More from ecancer